SCHEMBL28586143

SCHEMBL28586143

COc1cc2nccc(Oc3ccc(NC(=O)NC(=O)c4cc5c(Oc6ccc(NC(=O)NC7CC7)c(Cl)c6)ccnc5cc4OC)c(Cl)c3)c2cc1C(N)=O

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR4 P22455 11/20 0.91
RET P07949 6/20 0.91
KDR P35968 5/20 0.91
FGFR1 P11362 4/20 0.91
PDGFRB P09619 3/20 0.91
PDGFRA P16234 3/20 0.91
FGFR2 P21802 3/20 0.91
FGFR3 P22607 3/20 0.91
KIT P10721 2/20 0.91
FLT1 P17948 2/20 0.91
FLT4 P35916 2/20 0.91
AURKB Q96GD4 2/20 0.91
RIPK2 O43353 1/20 0.91
ERN1 O75460 1/20 0.91
STK10 O94804 1/20 0.91
MAP3K6 O95382 1/20 0.91
ABL1 P00519 1/20 0.91
ESR1 P03372 1/20 0.91
ADORA3 P0DMS8 1/20 0.91
BCR P11274 1/20 0.91

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lenvatinib SCHEMBL29372021 0.95 FGFR4 (1.00) FGFR4RETKDRFGFR1PDGFRB
Lenvatinib SCHEMBL864638 0.95 FGFR4 (1.00) FGFR4RETKDRFGFR1PDGFRB
Lenvatinib SCHEMBL29349806 0.95 FGFR4 (1.00) FGFR4RETKDRFGFR1PDGFRB
Lenvatinib SCHEMBL1389214 0.94 FGFR4 (0.98) FGFR4RETKDRFGFR1PDGFRB
Lenvatinib SCHEMBL865174 0.92 FGFR4 (0.94) FGFR4RETKDRFGFR1PDGFRB
Lenvatinib SCHEMBL29368684 0.92 FGFR4 (0.94) FGFR4RETKDRFGFR1PDGFRB
Lenvatinib SCHEMBL29357626 0.92 FGFR4 (0.94) FGFR4RETKDRFGFR1PDGFRB
SCHEMBL1248140 0.92 FGFR4 (0.87) FGFR4RETKDRFGFR1PDGFRB
Lenvatinib SCHEMBL3928020 0.91 FGFR4 (0.91) FGFR4RETKDRFGFR1PDGFRB
SCHEMBL863487 0.91 FGFR4 (0.85) FGFR4RETKDRFGFR1PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113045492-A Alvatinib mesylate impurity, and preparation method and detection method thereof 成都倍特药业股份有限公司 2021-06-29 CN disclosed